Anixa Biosciences
ANIX
71 hedge funds and large institutions have $17.8M invested in Anixa Biosciences in 2025 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 8 closing their positions.
526% more call options, than puts
Call options by funds: $144K | Put options by funds: $23K
63% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 8
46% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 13
8% more funds holding
Funds holding: 66 → 71 (+5)
0.85% more ownership
Funds ownership: 16.45% → 17.3% (+0.85%)
1% less capital invested
Capital invested by funds: $17.9M → $17.8M (-$113K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$703K |
| 2 |
6CM
683 Capital Management
New York
|
+$465K |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
+$385K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$244K |
| 5 |
VF
Virtu Financial
New York
|
+$212K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$853K |
| 2 |
MWM
Mission Wealth Management
Santa Barbara,
California
|
-$611K |
| 3 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
-$307K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$272K |
| 5 |
PWM
Prosperity Wealth Management
San Ramon,
California
|
-$138K |
ANIX Hedge Fund Activity: Q4 2025 in Review
71 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q4 2025, worth a combined $17.8M — down 0.63% from $17.9M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new ANIX positions and 8 closed out — a net gain of 5 holders — while 19 added to existing stakes and 13 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $703K. The largest seller was Bank of America, cutting an estimated $853K.
- 71 institutional investors held Anixa Biosciences (ANIX) as of Q4 2025, up from 66 in Q3 2025.
- Funds reported $17.8M of Anixa Biosciences stock for Q4 2025, down 0.63% quarter-over-quarter.
- 13 funds opened new Anixa Biosciences positions in Q4 2025 and 8 closed out, a net change of +5 holders.
- The largest Anixa Biosciences buyer in Q4 2025 was Susquehanna International Group, an estimated $703K added.
- The largest Anixa Biosciences seller in Q4 2025 was Bank of America, an estimated $853K sold.
Based on aggregated 13F filings for Q4 2025.